177 material Form 8-K filings that 165 companies we cover made with the SEC in April 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Hancock Whitney Corporation said Executive Vice President and Chief Banking Officer Cecil W. "Chip" Knight, Jr. will leave the company effective July 5, 2024, to pursue other interests. His banking responsibilities will move to D. Shane Loper, the company's Chief Operating Officer and president of Hancock Whitney Bank, and Commercial, Consumer, and Wealth Management will report directly to Loper.
Chip Knight, Jr., EVP and Chief Banking Officer, announced departure on April 25, 2024
Departure effective July 5, 2024; filing says he is leaving to pursue other interests
D. Shane Loper, COO and Hancock Whitney Bank President, assumes CBO responsibilities
Commercial, Consumer, and Wealth Management business lines will report directly to Loper
Saia's Executive Vice President and Chief Financial Officer, Douglas Col, plans to retire after 10 years with the company, including the last four as CFO. He will remain in the role until a successor is named and will stay on as an advisor through year-end to support the transition. The change is a senior finance leadership transition, though the filing contains no financial results or new guidance.
Douglas Col informed Saia of his retirement plans on April 23, 2024, after 10 years of service
Col will continue as CFO until the company names a successor and will serve as an advisor through year-end
Company announced the retirement in a press release dated April 26, 2024 (Exhibit 99.1)
Bio-Rad Laboratories said Simon May, Executive Vice President and President of the Life Science Group and a named executive officer, will resign effective May 1, 2024, to pursue another opportunity. James J. Barry, the company's Senior Vice President of Global Manufacturing, will take over that role on the same date. The filing also reports annual meeting votes, including stockholder approval of an amended 2017 Incentive Award Plan, but contains no financial results.
Simon May resigns as EVP and President, Life Science Group, effective May 1, 2024
James J. Barry appointed EVP and President, Life Science Group, effective May 1, 2024 (appointed April 24, 2024)
Stockholders approved the amended 2017 Incentive Award Plan at the April 23, 2024 annual meeting; plan expiration extended to February 9, 2034
Silicon Labs appointed Robert Conrad, a current board director, as Senior Vice President of Worldwide Operations, effective April 29, 2024, and he resigns from the board on starting work. Sandeep Kumar, who has led global operations, will leave his executive role and serve in a non-executive advisory role, departing in the second half of 2024. The filing puts the operations leadership change on record, along with pay terms for the new executive.
Conrad's base salary is $450,000, with a target bonus of 100% of base salary, prorated for 2024.
Expected May 15, 2024 equity grants total three awards of $1,000,000 each in grant date value, plus a $100,000 relocation bonus.
Conrad resigned from the board on April 18, 2024, effective when he starts as SVP.
Kumar will cease being SVP of Worldwide Operations on April 29, 2024 and depart the company in the second half of 2024.
Mueller Industries agreed on April 19, 2024 to acquire all outstanding equity of Nehring Electrical Works Company and affiliated entities, a wire and cable maker with about $400 million in 2023 annual net sales. The deal is expected to close in the second quarter of 2024, subject to regulatory approval, and will be funded with cash on hand, with management saying it is expected to be accretive to 2024 results.
Cash consideration of approximately $575 million, subject to customary purchase price adjustments, plus an additional $25 million earn out
Nehring's annual net sales for the twelve months ended December 31, 2023 were approximately $400 million
Agreement signed April 19, 2024; expected to close during the second quarter of 2024 subject to regulatory approval and customary conditions
Funded with cash on hand; Mueller says it will retain significant cash reserves after the transaction
Ciena said its Vice President, Principal Accounting Officer and Controller, Andrew C. Petrik, will retire effective April 25, 2025, about twelve months after notifying the company on April 22, 2024. He will remain in his role until then and help transition his duties to a successor.
Andrew C. Petrik, age 60, is Vice President, Principal Accounting Officer and Controller.
Retirement effective April 25, 2025; he notified the company on April 22, 2024.
He will continue in his role through the effective date and assist in transitioning responsibilities to a successor.
DoorDash appointed Jeffrey Blackburn, a former Amazon senior vice president, to its Board of Directors, effective May 6, 2024, and he will join the leadership development, inclusion and compensation committee. Director Greg Peters said he will not stand for re-election at the 2024 annual meeting, when his term ends. The filing reports no financial results, so the changes are governance matters for shareholders rather than a direct measure of performance.
Jeffrey Blackburn, age 54, elected to the board on April 18, 2024; term begins May 6, 2024 as a Class II director expiring at the 2025 annual meeting
Blackburn held senior roles at Amazon.com, including Senior Vice President of Global Media and Entertainment from May 2021 to February 2023
Greg Peters informed the company on April 15, 2024 that he will not stand for re-election; he remains a director until the 2024 Annual Meeting
VITAS Healthcare, a wholly owned subsidiary of Chemed, completed its $85 million purchase of substantially all hospice operations and an assisted living facility from Covenant Health and Community Services, effective April 17, 2024. The purchase was made with cash on hand, and the filing does not report financial results from the acquired operations.
Purchase price: $85 million, structured as an asset purchase, funded with cash on hand
Covenant hospice operations span the Florida panhandle and Alabama, including Pensacola, Tallahassee, Panama City and Dothan markets
Transaction was first announced on March 13, 2024 and closed effective April 17, 2024
Acadia Realty Trust and its operating partnership entered into a Third Amended and Restated Credit Agreement on April 15, 2024, with Bank of America, N.A. as administrative agent. The filing increases the revolving credit facility from $300.0 million to $350.0 million and extends both the revolver and the $400.0 million term loan to April 15, 2028, which gives the company a longer borrowing window.
Revolving credit facility increased from $300.0 million to $350.0 million, including up to $60.0 million for letters of credit
Maturity extended from June 29, 2025 to April 15, 2028, with two additional six-month extension options
$400.0 million term loan extended from June 29, 2026 to April 15, 2028; accordion feature allows capacity up to $900 million
As of closing, SOFR margins were 1.25% for revolver loans and 1.4% for term loan loans; the agreement includes financial covenants and limits on dividend payouts and distributions
Bio-Rad Laboratories' Executive Vice President and Chief Operating Officer, Dr. Andrew Last, notified the company on April 10, 2024 that he plans to retire by early September 2024. He will stay in his current role while Bio-Rad searches for a successor, which the company says is intended to ensure a smooth transition.
Dr. Andrew Last, EVP and Chief Operating Officer, intends to retire by early September 2024
Dr. Last will remain in his current position while the company searches for a successor
Dr. Last joined Bio-Rad in April 2019; CEO Norman Schwartz credited him with cost structure, core process and supply chain improvements
Comstock Resources, Inc. issued $400.0 million of 6.75% senior notes due March 1, 2029, in a private placement dated April 9, 2024. The notes are senior unsecured obligations guaranteed by the company's subsidiaries, which adds debt to the company's balance sheet and carries interest payments until maturity.
Notes: $400.0 million aggregate principal, 6.75% senior notes due March 1, 2029, issued April 9, 2024
Interest of 6.75% per year, paid semi-annually on March 1 and September 1, starting September 1, 2024
Notes are effectively subordinated to secured debt, including borrowings under the bank credit facility
Holders may require repurchase at 101% of principal upon a Change of Control Triggering Event
Garmin disclosed that General Counsel Andrew R. Etkind informed the board on April 2, 2024, that he intends to step down from that role effective July 1, 2024. Joshua H. Maxfield will become Vice President, General Counsel and Assistant Secretary, and Etkind will remain Vice President and Secretary. The filing describes an internal leadership handover and does not report any financial results or impact on company guidance.
Andrew R. Etkind informed the board on April 2, 2024 of his intention to step down as General Counsel
Step-down is effective July 1, 2024
Joshua H. Maxfield will assume the role of Vice President, General Counsel and Assistant Secretary
Etkind will continue as Vice President and Secretary after July 1, 2024
PHINIA issued $525 million of 6.75% senior secured notes due 2029, upsized from $425 million, and proceeds will repay term loan B and revolving credit borrowings. The company also amended its credit agreement, raising the total net leverage covenant from 3.00:1.00 to 3.25:1.00 and removing the mandatory prepayment tied to operating cash flow, which adds debt to the balance sheet but refinances existing borrowings.
Notes issued April 4, 2024 at 100.00% of principal, $525 million, up from $425 million planned
Interest of 6.75% per year, paid semiannually on April 15 and October 15, first payment October 15, 2024; maturity April 15, 2029
Proceeds to repay all outstanding term loan B and revolving credit borrowings, pay fees, and for general corporate purposes
Credit agreement amendment with Bank of America, N.A. raises net leverage covenant to 3.25:1.00 from 3.00:1.00
Innospec's Executive Vice President and Chief Operating Officer, Dr. Philip Boon, has informed the company he will retire effective March 31, 2025. After retirement he will provide support to the company on a consultancy basis, with terms to be agreed.
Dr. Philip Boon, EVP and Chief Operating Officer, notified the company on March 31, 2024.
Retirement is effective March 31, 2025, giving the company about one year of notice.
Boon will provide support on a consultancy basis after retirement, on terms still to be agreed.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.